BRAF and cutaneous melanoma: In a review on the role of BRAF in pathogenesis of papillary thyroid carcinoma and cutaneous melanoma, Mitchell et al. concluded that the BRAF protein acts as a catalyst for epithelial–mesenchymal transition in both malignancies [11].